GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Interleukin-23 receptor (IL-23 receptor) (IL-23R)

 IL23R_HUMAN             Reviewed;         629 AA.
Q5VWK5; C9JGX4; Q4VGP1; Q4VGP2; Q4VGP3; Q4VGP4; Q4VGP5; Q4VGP6;
Q5VWK7; Q8IW84; Q8NFQ9; Q96AS1;
12-DEC-2006, integrated into UniProtKB/Swiss-Prot.
02-NOV-2010, sequence version 3.
31-JUL-2019, entry version 136.
RecName: Full=Interleukin-23 receptor;
Short=IL-23 receptor;
Short=IL-23R;
Flags: Precursor;
Name=IL23R;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH
IL23; IL12RB1; JAK2 AND STAT3, PHOSPHORYLATION, TISSUE SPECIFICITY,
SUBCELLULAR LOCATION, AND VARIANT PRO-310.
TISSUE=Natural killer cell, and T-cell;
PubMed=12023369; DOI=10.4049/jimmunol.168.11.5699;
Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J.,
Pflanz S., Zhang R., Singh K.P., Vega F., To W., Wagner J.,
O'Farrell A.-M., McClanahan T.K., Zurawski S., Hannum C., Gorman D.,
Rennick D.M., Kastelein R.A., de Waal Malefyt R., Moore K.W.;
"A receptor for the heterodimeric cytokine IL-23 is composed of IL-
12Rbeta1 and a novel cytokine receptor subunit, IL-23R.";
J. Immunol. 168:5699-5708(2002).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 5), NUCLEOTIDE SEQUENCE
[MRNA] OF 37-629 (ISOFORMS 1; 3 AND 4), TISSUE SPECIFICITY, AND
VARIANT PRO-310.
TISSUE=Bone marrow;
PubMed=16372191; DOI=10.1007/s00251-005-0067-0;
Zhang X.-Y., Zhang H.-J., Zhang Y., Fu Y.-J., He J., Zhu L.-P.,
Wang S.-H., Liu L.;
"Identification and expression analysis of alternatively spliced
isoforms of human interleukin-23 receptor gene in normal lymphoid
cells and selected tumor cells.";
Immunogenetics 57:934-943(2006).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16710414; DOI=10.1038/nature04727;
Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
Beck S., Rogers J., Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 6 AND 7), AND VARIANT
PRO-310.
TISSUE=Bone marrow, and Skin;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[5]
INVOLVEMENT IN IBD17, VARIANTS HIS-3; PRO-310 AND GLN-381, AND
CHARACTERIZATION OF VARIANT GLN-381.
PubMed=17068223; DOI=10.1126/science.1135245;
Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S.,
Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A.,
Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W.,
Kistner E.O., Schumm L.P., Lee A.T., Gregersen P.K., Barmada M.M.,
Rotter J.I., Nicolae D.L., Cho J.H.;
"A genome-wide association study identifies IL23R as an inflammatory
bowel disease gene.";
Science 314:1461-1463(2006).
[6]
VARIANT GLN-381, AND CHARACTERIZATION OF VARIANT GLN-381.
PubMed=17587057; DOI=10.1007/s00439-007-0397-0;
Capon F., Di Meglio P., Szaub J., Prescott N.J., Dunster C.,
Baumber L., Timms K., Gutin A., Abkevic V., Burden A.D., Lanchbury J.,
Barker J.N., Trembath R.C., Nestle F.O.;
"Sequence variants in the genes for the interleukin-23 receptor
(IL23R) and its ligand (IL12B) confer protection against psoriasis.";
Hum. Genet. 122:201-206(2007).
[7]
INVOLVEMENT IN IBD17, AND VARIANT GLN-381.
PubMed=17804789; DOI=10.1073/pnas.0706645104;
Raelson J.V., Little R.D., Ruether A., Fournier H., Paquin B.,
Van Eerdewegh P., Bradley W.E.C., Croteau P., Nguyen-Huu Q., Segal J.,
Debrus S., Allard R., Rosenstiel P., Franke A., Jacobs G.,
Nikolaus S., Vidal J.-M., Szego P., Laplante N., Clark H.F.,
Paulussen R.J., Hooper J.W., Keith T.P., Belouchi A., Schreiber S.;
"Genome-wide association study for Crohn's disease in the Quebec
founder population identifies multiple validated disease loci.";
Proc. Natl. Acad. Sci. U.S.A. 104:14747-14752(2007).
[8]
VARIANTS PRO-310 AND GLN-381, AND CHARACTERIZATION OF VARIANT GLN-381.
PubMed=18800148; DOI=10.1038/jid.2008.233;
Huffmeier U., Lascorz J., Bohm B., Lohmann J., Wendler J., Mossner R.,
Reich K., Traupe H., Kurrat W., Burkhardt H., Reis A.;
"Genetic variants of the IL-23R pathway: association with psoriatic
arthritis and psoriasis vulgaris, but no specific risk factor for
arthritis.";
J. Invest. Dermatol. 129:355-358(2009).
[9]
GLYCOSYLATION AT ASN-29; ASN-47; ASN-81; ASN-141; ASN-180; ASN-232;
ASN-262 AND ASN-273.
PubMed=21053369; DOI=10.1002/jms.1858;
Zhao J., Liu Y.H., Reichert P., Pflanz S., Pramanik B.;
"Glycosylation analysis of interleukin-23 receptor: elucidation of
glycosylation sites and characterization of attached glycan
structures.";
J. Mass Spectrom. 45:1416-1425(2010).
-!- FUNCTION: Associates with IL12RB1 to form the interleukin-23
receptor. Binds IL23 and mediates T-cells, NK cells and possibly
certain macrophage/myeloid cells stimulation probably through
activation of the Jak-Stat signaling cascade. IL23 functions in
innate and adaptive immunity and may participate in acute response
to infection in peripheral tissues. IL23 may be responsible for
autoimmune inflammatory diseases and be important for
tumorigenesis. {ECO:0000269|PubMed:12023369}.
-!- SUBUNIT: Heterodimer with IL12RB1. In presence of IL23, the
heterodimer forms the IL23 receptor. Interacts with JAK2 and in
presence of IL23 with STAT3. {ECO:0000269|PubMed:12023369}.
-!- INTERACTION:
Q13901:C1D; NbExp=3; IntAct=EBI-10248005, EBI-3844053;
Q62120:Jak2 (xeno); NbExp=2; IntAct=EBI-10248005, EBI-646604;
-!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12023369};
Single-pass type I membrane protein {ECO:0000269|PubMed:12023369}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=7;
Name=1; Synonyms=IL-23R1;
IsoId=Q5VWK5-1; Sequence=Displayed;
Name=2; Synonyms=IL-23R2-F2;
IsoId=Q5VWK5-2; Sequence=VSP_021993;
Note=Produced by translation in an alternate frame of the cDNA
encoding isoform 4. No experimental confirmation available.;
Name=3; Synonyms=IL-23R3-F1;
IsoId=Q5VWK5-3; Sequence=VSP_021997, VSP_021998;
Note=Produced by translation in an alternate frame of the cDNA
encoding isoform 5. No experimental confirmation available.;
Name=4; Synonyms=IL-23R2-F1;
IsoId=Q5VWK5-4; Sequence=VSP_021994, VSP_021995;
Note=Produced by translation in an alternate frame of the cDNA
encoding isoform 2. No experimental confirmation available.;
Name=5; Synonyms=IL-23R3-F3;
IsoId=Q5VWK5-5; Sequence=VSP_021991, VSP_021999;
Note=Produced by translation in an alternate frame of the cDNA
encoding isoform 3. No experimental confirmation available.;
Name=6; Synonyms=IL-23R6;
IsoId=Q5VWK5-6; Sequence=VSP_021992, VSP_021996;
Note=No experimental confirmation available.;
Name=7; Synonyms=IL-23R5;
IsoId=Q5VWK5-7; Sequence=VSP_021990;
Note=No experimental confirmation available.;
-!- TISSUE SPECIFICITY: Expressed by monocytes, Th1, Th0, NK and
dendritic cells. Isoform 1 is specifically expressed in NK cells.
{ECO:0000269|PubMed:12023369, ECO:0000269|PubMed:16372191}.
-!- PTM: Phosphorylated in response to IL23.
{ECO:0000269|PubMed:12023369}.
-!- DISEASE: Inflammatory bowel disease 17 (IBD17) [MIM:612261]: A
chronic, relapsing inflammation of the gastrointestinal tract with
a complex etiology. It is subdivided into Crohn disease and
ulcerative colitis phenotypes. Crohn disease may affect any part
of the gastrointestinal tract from the mouth to the anus, but most
frequently it involves the terminal ileum and colon. Bowel
inflammation is transmural and discontinuous; it may contain
granulomas or be associated with intestinal or perianal fistulas.
In contrast, in ulcerative colitis, the inflammation is continuous
and limited to rectal and colonic mucosal layers; fistulas and
granulomas are not observed. Both diseases include extraintestinal
inflammation of the skin, eyes, or joints.
{ECO:0000269|PubMed:17068223, ECO:0000269|PubMed:17804789}.
Note=Disease susceptibility is associated with variations
affecting the gene represented in this entry.
-!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 2
subfamily. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAH16829.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AF461422; AAM44229.1; -; mRNA.
EMBL; AY937250; AAY18345.1; -; mRNA.
EMBL; AY937251; AAY18346.1; -; mRNA.
EMBL; AY937252; AAY18347.1; -; mRNA.
EMBL; AY937253; AAY18348.1; -; mRNA.
EMBL; AY937254; AAY18349.1; -; mRNA.
EMBL; AY937255; AAY18350.1; -; mRNA.
EMBL; AL109843; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; AL389925; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC016829; AAH16829.1; ALT_INIT; mRNA.
EMBL; BC040720; AAH40720.1; -; mRNA.
CCDS; CCDS637.1; -. [Q5VWK5-1]
RefSeq; NP_653302.2; NM_144701.2. [Q5VWK5-1]
RefSeq; XP_005270573.1; XM_005270516.2. [Q5VWK5-2]
RefSeq; XP_011539092.1; XM_011540790.2. [Q5VWK5-1]
RefSeq; XP_011539093.1; XM_011540791.2. [Q5VWK5-1]
PDB; 5MZV; X-ray; 2.80 A; C=1-317.
PDBsum; 5MZV; -.
SMR; Q5VWK5; -.
BioGrid; 127199; 3.
ComplexPortal; CPX-383; Interleukin-23-receptor complex.
IntAct; Q5VWK5; 6.
STRING; 9606.ENSP00000321345; -.
iPTMnet; Q5VWK5; -.
PhosphoSitePlus; Q5VWK5; -.
UniCarbKB; Q5VWK5; -.
BioMuta; IL23R; -.
DMDM; 311033431; -.
PaxDb; Q5VWK5; -.
PeptideAtlas; Q5VWK5; -.
PRIDE; Q5VWK5; -.
ProteomicsDB; 65533; -. [Q5VWK5-1]
ProteomicsDB; 65534; -. [Q5VWK5-2]
ProteomicsDB; 65535; -. [Q5VWK5-3]
ProteomicsDB; 65536; -. [Q5VWK5-4]
ProteomicsDB; 65537; -. [Q5VWK5-5]
ProteomicsDB; 65538; -. [Q5VWK5-6]
ProteomicsDB; 65539; -. [Q5VWK5-7]
DNASU; 149233; -.
Ensembl; ENST00000347310; ENSP00000321345; ENSG00000162594. [Q5VWK5-1]
Ensembl; ENST00000395227; ENSP00000378652; ENSG00000162594. [Q5VWK5-7]
Ensembl; ENST00000425614; ENSP00000387640; ENSG00000162594. [Q5VWK5-6]
GeneID; 149233; -.
KEGG; hsa:149233; -.
UCSC; uc001ddo.4; human. [Q5VWK5-1]
CTD; 149233; -.
DisGeNET; 149233; -.
GeneCards; IL23R; -.
HGNC; HGNC:19100; IL23R.
HPA; HPA056427; -.
MalaCards; IL23R; -.
MIM; 607562; gene.
MIM; 612261; phenotype.
neXtProt; NX_Q5VWK5; -.
OpenTargets; ENSG00000162594; -.
Orphanet; 117; Behcet disease.
Orphanet; 206; NON RARE IN EUROPE: Crohn disease.
Orphanet; 771; NON RARE IN EUROPE: Ulcerative colitis.
PharmGKB; PA134935109; -.
eggNOG; ENOG410IHH9; Eukaryota.
eggNOG; ENOG410YRR7; LUCA.
GeneTree; ENSGT00530000064198; -.
InParanoid; Q5VWK5; -.
KO; K05065; -.
OMA; GNMTCTW; -.
OrthoDB; 144839at2759; -.
PhylomeDB; Q5VWK5; -.
TreeFam; TF335930; -.
Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
Reactome; R-HSA-9020933; Interleukin-23 signaling.
SignaLink; Q5VWK5; -.
SIGNOR; Q5VWK5; -.
ChiTaRS; IL23R; human.
GeneWiki; Interleukin-23_receptor; -.
GenomeRNAi; 149233; -.
PRO; PR:Q5VWK5; -.
Proteomes; UP000005640; Chromosome 1.
Bgee; ENSG00000162594; Expressed in 32 organ(s), highest expression level in secondary oocyte.
ExpressionAtlas; Q5VWK5; baseline and differential.
Genevisible; Q5VWK5; HS.
GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
GO; GO:0072536; C:interleukin-23 receptor complex; IDA:BHF-UCL.
GO; GO:0005886; C:plasma membrane; TAS:Reactome.
GO; GO:0043235; C:receptor complex; IDA:MGI.
GO; GO:0019955; F:cytokine binding; IBA:GO_Central.
GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central.
GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
GO; GO:0050829; P:defense response to Gram-negative bacterium; IC:BHF-UCL.
GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
GO; GO:0038155; P:interleukin-23-mediated signaling pathway; TAS:Reactome.
GO; GO:0032693; P:negative regulation of interleukin-10 production; IMP:BHF-UCL.
GO; GO:0042104; P:positive regulation of activated T cell proliferation; IC:BHF-UCL.
GO; GO:0010536; P:positive regulation of activation of Janus kinase activity; IC:BHF-UCL.
GO; GO:0002230; P:positive regulation of defense response to virus by host; IDA:BHF-UCL.
GO; GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; IC:BHF-UCL.
GO; GO:0032729; P:positive regulation of interferon-gamma production; IDA:BHF-UCL.
GO; GO:0032735; P:positive regulation of interleukin-12 production; IDA:BHF-UCL.
GO; GO:0032740; P:positive regulation of interleukin-17 production; IC:BHF-UCL.
GO; GO:0043382; P:positive regulation of memory T cell differentiation; ISS:BHF-UCL.
GO; GO:0032819; P:positive regulation of natural killer cell proliferation; IC:BHF-UCL.
GO; GO:0051135; P:positive regulation of NK T cell activation; IC:BHF-UCL.
GO; GO:0045672; P:positive regulation of osteoclast differentiation; IC:BHF-UCL.
GO; GO:0001916; P:positive regulation of T cell mediated cytotoxicity; ISS:BHF-UCL.
GO; GO:0042102; P:positive regulation of T cell proliferation; IC:BHF-UCL.
GO; GO:0002827; P:positive regulation of T-helper 1 type immune response; IDA:BHF-UCL.
GO; GO:2000330; P:positive regulation of T-helper 17 cell lineage commitment; ISS:BHF-UCL.
GO; GO:2000318; P:positive regulation of T-helper 17 type immune response; ISS:BHF-UCL.
GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IC:BHF-UCL.
GO; GO:0042509; P:regulation of tyrosine phosphorylation of STAT protein; IC:BHF-UCL.
GO; GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL.
GO; GO:0032496; P:response to lipopolysaccharide; IDA:BHF-UCL.
Gene3D; 2.60.40.10; -; 2.
InterPro; IPR003961; FN3_dom.
InterPro; IPR036116; FN3_sf.
InterPro; IPR013783; Ig-like_fold.
SUPFAM; SSF49265; SSF49265; 2.
PROSITE; PS50853; FN3; 2.
1: Evidence at protein level;
3D-structure; Alternative splicing; Cell membrane; Complete proteome;
Glycoprotein; Immunity; Inflammatory response; Innate immunity;
Membrane; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
Repeat; Signal; Transmembrane; Transmembrane helix.
SIGNAL 1 23 {ECO:0000255}.
CHAIN 24 629 Interleukin-23 receptor.
/FTId=PRO_0000268662.
TOPO_DOM 24 355 Extracellular. {ECO:0000255}.
TRANSMEM 356 376 Helical. {ECO:0000255}.
TOPO_DOM 377 629 Cytoplasmic. {ECO:0000255}.
DOMAIN 127 217 Fibronectin type-III 1.
{ECO:0000255|PROSITE-ProRule:PRU00316}.
DOMAIN 219 318 Fibronectin type-III 2.
{ECO:0000255|PROSITE-ProRule:PRU00316}.
CARBOHYD 29 29 N-linked (GlcNAc...) asparagine; partial.
{ECO:0000269|PubMed:21053369}.
CARBOHYD 47 47 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:21053369}.
CARBOHYD 81 81 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:21053369}.
CARBOHYD 141 141 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:21053369}.
CARBOHYD 180 180 N-linked (GlcNAc...) (high mannose)
asparagine.
{ECO:0000269|PubMed:21053369}.
CARBOHYD 232 232 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:21053369}.
CARBOHYD 262 262 N-linked (GlcNAc...) asparagine.
{ECO:0000269|PubMed:21053369}.
CARBOHYD 273 273 N-linked (GlcNAc...) asparagine; partial.
{ECO:0000269|PubMed:21053369}.
VAR_SEQ 1 402 Missing (in isoform 7).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_021990.
VAR_SEQ 1 365 Missing (in isoform 5).
{ECO:0000303|PubMed:16372191}.
/FTId=VSP_021991.
VAR_SEQ 1 255 Missing (in isoform 6).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_021992.
VAR_SEQ 1 254 Missing (in isoform 2).
{ECO:0000303|PubMed:16372191}.
/FTId=VSP_021993.
VAR_SEQ 165 174 LETEEEQQYL -> DTFCSRHFQG (in isoform 4).
{ECO:0000303|PubMed:16372191}.
/FTId=VSP_021994.
VAR_SEQ 175 629 Missing (in isoform 4).
{ECO:0000303|PubMed:16372191}.
/FTId=VSP_021995.
VAR_SEQ 256 266 RYKATTNQTWN -> MILRPYQPCGT (in isoform
6). {ECO:0000303|PubMed:15489334}.
/FTId=VSP_021996.
VAR_SEQ 349 356 DNRGDIGL -> GLKEGSYC (in isoform 3).
{ECO:0000303|PubMed:16372191}.
/FTId=VSP_021997.
VAR_SEQ 357 629 Missing (in isoform 3).
{ECO:0000303|PubMed:16372191}.
/FTId=VSP_021998.
VAR_SEQ 366 383 MLSILSLIGIFNRSFRTG -> MEFWANSCFHLYRAPYFW
(in isoform 5).
{ECO:0000303|PubMed:16372191}.
/FTId=VSP_021999.
VARIANT 3 3 Q -> H (in dbSNP:rs1884444).
{ECO:0000269|PubMed:17068223}.
/FTId=VAR_029752.
VARIANT 175 175 T -> N (in dbSNP:rs11465797).
/FTId=VAR_047955.
VARIANT 310 310 L -> P (in dbSNP:rs7530511).
{ECO:0000269|PubMed:12023369,
ECO:0000269|PubMed:15489334,
ECO:0000269|PubMed:16372191,
ECO:0000269|PubMed:17068223,
ECO:0000269|PubMed:18800148}.
/FTId=VAR_029753.
VARIANT 381 381 R -> Q (polymorphism; associated with
reduced disease susceptibility; has a
protective effect against Crohn disease
and psoriasis; dbSNP:rs11209026).
{ECO:0000269|PubMed:17068223,
ECO:0000269|PubMed:17587057,
ECO:0000269|PubMed:17804789,
ECO:0000269|PubMed:18800148}.
/FTId=VAR_029754.
CONFLICT 46 46 M -> T (in Ref. 2; AAY18346).
{ECO:0000305}.
CONFLICT 133 133 C -> R (in Ref. 2; AAY18348).
{ECO:0000305}.
CONFLICT 302 302 R -> G (in Ref. 2; AAY18348).
{ECO:0000305}.
CONFLICT 475 475 V -> A (in Ref. 2; AAY18347).
{ECO:0000305}.
CONFLICT 481 481 N -> D (in Ref. 2; AAY18347).
{ECO:0000305}.
CONFLICT 581 581 S -> R (in Ref. 2; AAY18349).
{ECO:0000305}.
STRAND 31 38 {ECO:0000244|PDB:5MZV}.
STRAND 40 43 {ECO:0000244|PDB:5MZV}.
STRAND 48 54 {ECO:0000244|PDB:5MZV}.
STRAND 64 68 {ECO:0000244|PDB:5MZV}.
STRAND 75 81 {ECO:0000244|PDB:5MZV}.
STRAND 84 91 {ECO:0000244|PDB:5MZV}.
STRAND 95 104 {ECO:0000244|PDB:5MZV}.
STRAND 109 122 {ECO:0000244|PDB:5MZV}.
STRAND 129 136 {ECO:0000244|PDB:5MZV}.
STRAND 141 147 {ECO:0000244|PDB:5MZV}.
STRAND 157 164 {ECO:0000244|PDB:5MZV}.
TURN 165 167 {ECO:0000244|PDB:5MZV}.
STRAND 170 177 {ECO:0000244|PDB:5MZV}.
STRAND 179 182 {ECO:0000244|PDB:5MZV}.
HELIX 183 185 {ECO:0000244|PDB:5MZV}.
STRAND 190 200 {ECO:0000244|PDB:5MZV}.
STRAND 203 206 {ECO:0000244|PDB:5MZV}.
STRAND 210 213 {ECO:0000244|PDB:5MZV}.
TURN 214 216 {ECO:0000244|PDB:5MZV}.
STRAND 217 219 {ECO:0000244|PDB:5MZV}.
STRAND 223 230 {ECO:0000244|PDB:5MZV}.
STRAND 233 235 {ECO:0000244|PDB:5MZV}.
STRAND 237 244 {ECO:0000244|PDB:5MZV}.
STRAND 249 259 {ECO:0000244|PDB:5MZV}.
STRAND 266 270 {ECO:0000244|PDB:5MZV}.
STRAND 278 283 {ECO:0000244|PDB:5MZV}.
STRAND 290 298 {ECO:0000244|PDB:5MZV}.
SEQUENCE 629 AA; 71722 MW; AC63C89E81AABF05 CRC64;
MNQVTIQWDA VIALYILFSW CHGGITNINC SGHIWVEPAT IFKMGMNISI YCQAAIKNCQ
PRKLHFYKNG IKERFQITRI NKTTARLWYK NFLEPHASMY CTAECPKHFQ ETLICGKDIS
SGYPPDIPDE VTCVIYEYSG NMTCTWNAGK LTYIDTKYVV HVKSLETEEE QQYLTSSYIN
ISTDSLQGGK KYLVWVQAAN ALGMEESKQL QIHLDDIVIP SAAVISRAET INATVPKTII
YWDSQTTIEK VSCEMRYKAT TNQTWNVKEF DTNFTYVQQS EFYLEPNIKY VFQVRCQETG
KRYWQPWSSL FFHKTPETVP QVTSKAFQHD TWNSGLTVAS ISTGHLTSDN RGDIGLLLGM
IVFAVMLSIL SLIGIFNRSF RTGIKRRILL LIPKWLYEDI PNMKNSNVVK MLQENSELMN
NNSSEQVLYV DPMITEIKEI FIPEHKPTDY KKENTGPLET RDYPQNSLFD NTTVVYIPDL
NTGYKPQISN FLPEGSHLSN NNEITSLTLK PPVDSLDSGN NPRLQKHPNF AFSVSSVNSL
SNTIFLGELS LILNQGECSS PDIQNSVEEE TTMLLENDSP SETIPEQTLL PDEFVSCLGI
VNEELPSINT YFPQNILESH FNRISLLEK


Related products :

Catalog number Product name Quantity
E0066h ELISA CD121 antigen-like family member B,CDw121b,Homo sapiens,Human,IL1R2,IL-1R-2,IL1RB,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor typ 96T
U0066h CLIA CD121 antigen-like family member B,CDw121b,Homo sapiens,Human,IL1R2,IL-1R-2,IL1RB,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type 96T
E0066m ELISA CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Mouse,Mus muscu 96T
U0065m CLIA CD121 antigen-like family member A,Il1r1,Il-1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,Mouse,Mus muscu 96T
U0066r CLIA CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Rat,Rattus norve 96T
U0066m CLIA CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Mouse,Mus muscul 96T
E0066r ELISA CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Rat,Rattus norv 96T
E0065m ELISA CD121 antigen-like family member A,Il1r1,Il-1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,Mouse,Mus musc 96T
E0065r ELISA CD121 antigen-like family member A,Il1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,p80,Rat,Rattus norveg 96T
U0065r CLIA CD121 antigen-like family member A,Il1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,p80,Rat,Rattus norvegi 96T
E0066m ELISA kit CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Mouse,Mus 96T
E0065r ELISA kit CD121 antigen-like family member A,Il1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,p80,Rat,Rattus n 96T
E0066r ELISA kit CD121 antigen-like family member B,Il1r2,Il-1r2,IL-1R-2,Il1rb,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 receptor type II,Rat,Rattus 96T
E0065m ELISA kit CD121 antigen-like family member A,Il1r1,Il-1r1,IL-1R-1,Il1ra,IL-1R-alpha,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 receptor type I,Mouse,Mus 96T
orb82731 Human IL4 protein Interleukin-4 (IL4) is a pleiotropic cytokine produced by activated T cells. IL4 is a ligandfor interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which maycontri 1 mg
E2006h ELISA CDw128b,C-X-C chemokine receptor type 2,CXCR2,CXC-R2,CXCR-2,GRO_MGSA receptor,High affinity interleukin-8 receptor B,Homo sapiens,Human,IL-8 receptor type 2,IL-8R B,IL8RB 96T
U2006h CLIA CDw128b,C-X-C chemokine receptor type 2,CXCR2,CXC-R2,CXCR-2,GRO_MGSA receptor,High affinity interleukin-8 receptor B,Homo sapiens,Human,IL-8 receptor type 2,IL-8R B,IL8RB 96T
U2006h CLIA kit CDw128b,C-X-C chemokine receptor type 2,CXCR2,CXC-R2,CXCR-2,GRO_MGSA receptor,High affinity interleukin-8 receptor B,Homo sapiens,Human,IL-8 receptor type 2,IL-8R B,IL8RB 96T
E2006h ELISA kit CDw128b,C-X-C chemokine receptor type 2,CXCR2,CXC-R2,CXCR-2,GRO_MGSA receptor,High affinity interleukin-8 receptor B,Homo sapiens,Human,IL-8 receptor type 2,IL-8R B,IL8RB 96T
E0065h ELISA kit CD121 antigen-like family member A,Homo sapiens,Human,IL1R,IL1R1,IL-1R-1,IL1RA,IL-1R-alpha,IL1RT1,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 r 96T
E0066h ELISA kit CD121 antigen-like family member B,CDw121b,Homo sapiens,Human,IL1R2,IL-1R-2,IL1RB,IL-1R-beta,IL-1RT2,IL-1RT-2,Interleukin-1 receptor beta,Interleukin-1 receptor type 2,Interleukin-1 recepto 96T
U0065h CLIA CD121 antigen-like family member A,Homo sapiens,Human,IL1R,IL1R1,IL-1R-1,IL1RA,IL-1R-alpha,IL1RT1,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 recepto 96T
E0065h ELISA CD121 antigen-like family member A,Homo sapiens,Human,IL1R,IL1R1,IL-1R-1,IL1RA,IL-1R-alpha,IL1RT1,IL-1RT1,IL-1RT-1,Interleukin-1 receptor alpha,Interleukin-1 receptor type 1,Interleukin-1 recept 96T
E2006r ELISA kit C-X-C chemokine receptor type 2,Cxcr2,CXC-R2,CXCR-2,GRO_MGSA receptor,High affinity interleukin-8 receptor B,IL-8R B,Il8rb,Rat,Rattus norvegicus 96T
E2006r ELISA C-X-C chemokine receptor type 2,Cxcr2,CXC-R2,CXCR-2,GRO_MGSA receptor,High affinity interleukin-8 receptor B,IL-8R B,Il8rb,Rat,Rattus norvegicus 96T
Pathways :
WP1384: Toll-like receptor signaling pathway
WP407: Kit Receptor Signaling Pathway
WP1161: TGF-beta Receptor Signaling Pathway
WP2197: Endothelin
WP783: Androgen Receptor Signaling Pathway
WP1206: Signaling of Hepatocyte Growth Factor Receptor
WP23: B Cell Receptor Signaling Pathway
WP810: Signaling of Hepatocyte Growth Factor Receptor
WP1781: Advanced glycosylation endproduct receptor signaling
WP480: T Cell Receptor Signaling Pathway
WP581: EPO Receptor Signaling
WP1271: Toll-like receptor signaling pathway
WP2355: Corticotropin-releasing hormone
WP88: Toll Like Receptor signaling
WP1014: Androgen receptor signaling pathway
WP1336: EPO Receptor Signaling
WP26: Signal Transduction of S1P Receptor
WP897: Androgen receptor signaling pathway
WP1046: Signaling of Hepatocyte Growth Factor Receptor
WP1918: Signaling by Robo receptor
WP732: Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
WP1965: VEGF-receptor Signal Transduction
WP75: Toll-like receptor signaling pathway
WP1348: Androgen Receptor Signaling Pathway
WP304: Kit receptor signaling pathway

Related Genes :
[IL23R] Interleukin-23 receptor (IL-23 receptor) (IL-23R)
[IL12RB1 IL12R IL12RB] Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212)
[IL23A SGRF UNQ2498/PRO5798] Interleukin-23 subunit alpha (IL-23 subunit alpha) (IL-23-A) (Interleukin-23 subunit p19) (IL-23p19)
[Il12rb1 Il12rb] Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12 receptor beta component) (CD antigen CD212)
[Il23a] Interleukin-23 subunit alpha (IL-23 subunit alpha) (IL-23-A) (Interleukin-23 subunit p19) (IL-23p19)
[IFNLR1 IL28RA LICR2] Interferon lambda receptor 1 (IFN-lambda receptor 1) (IFN-lambda-R1) (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12) (CRF2-12) (Interleukin-28 receptor subunit alpha) (IL-28 receptor subunit alpha) (IL-28R-alpha) (IL-28RA) (Likely interleukin or cytokine receptor 2) (LICR2)
[IL1R1 IL1R IL1RA IL1RT1] Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]
[IL4R IL4RA 582J2.1] Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)]
[IL10RA IL10R] Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210)
[IL1RAP C3orf13 IL1R3] Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3)
[IL6ST] Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)
[IL1RAPL1 OPHN4] Interleukin-1 receptor accessory protein-like 1 (IL-1-RAPL-1) (IL-1RAPL-1) (IL1RAPL-1) (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2) (TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1)
[IL2RG] Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132)
[Il11ra1 Etl2 Il11ra] Interleukin-11 receptor subunit alpha-1 (IL-11 receptor subunit alpha-1) (IL-11R subunit alpha-1) (IL-11R-alpha-1) (IL-11RA1) (Enhancer trap locus homolog 2) (Etl-2) (Novel cytokine receptor 1) (NR-1) (NR1)
[IL6R] Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126)
[IL18RAP IL1R7] Interleukin-18 receptor accessory protein (IL-18 receptor accessory protein) (IL-18RAcP) (Accessory protein-like) (AcPL) (CD218 antigen-like family member B) (CDw218b) (IL-1R accessory protein-like) (IL-1RAcPL) (Interleukin-1 receptor 7) (IL-1R-7) (IL-1R7) (Interleukin-18 receptor accessory protein-like) (Interleukin-18 receptor beta) (IL-18R-beta) (IL-18Rbeta) (CD antigen CD218b)
[Il1r1 Il-1r1 Il1ra] Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]
[IL11RA] Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA)
[Il1r1 Il1ra] Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]
[IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342] Interleukin-36 receptor antagonist protein (IL-36Ra) (FIL1 delta) (IL-1-related protein 3) (IL-1RP3) (Interleukin-1 HY1) (IL-1HY1) (Interleukin-1 delta) (IL-1 delta) (Interleukin-1 family member 5) (IL-1F5) (Interleukin-1 receptor antagonist homolog 1) (IL-1ra homolog 1) (Interleukin-1-like protein 1) (IL-1L1)
[IL37 FIL1Z IL1F7 IL1H4 IL1RP1] Interleukin-37 (FIL1 zeta) (IL-1X) (Interleukin-1 family member 7) (IL-1F7) (Interleukin-1 homolog 4) (IL-1H) (IL-1H4) (Interleukin-1 zeta) (IL-1 zeta) (Interleukin-1-related protein) (IL-1RP1) (Interleukin-23) (IL-37)
[Il4r Il4ra] Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)]
[IL17RC UNQ6118/PRO20040/PRO38901] Interleukin-17 receptor C (IL-17 receptor C) (IL-17RC) (Interleukin-17 receptor homolog) (IL17Rhom) (Interleukin-17 receptor-like protein) (IL-17RL) (ZcytoR14)
[IL10RB CRFB4 D21S58 D21S66] Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b)
[IL17RA IL17R] Interleukin-17 receptor A (IL-17 receptor A) (IL-17RA) (CDw217) (CD antigen CD217)
[IL17RB CRL4 EVI27 IL17BR UNQ2501/PRO19612] Interleukin-17 receptor B (IL-17 receptor B) (IL-17RB) (Cytokine receptor-like 4) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Interleukin-17B receptor) (IL-17B receptor)
[IL18R1 IL1RRP] Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (Interleukin-18 receptor alpha) (IL-18R-alpha) (IL-18Ralpha) (CD antigen CD218a)
[IL2RB IL15RB] Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122)
[Il18r1] Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (CD218 antigen-like family member A) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (Interleukin-18 receptor alpha) (IL-18R-alpha) (IL-18Ralpha) (CD antigen CD218a)
[Il6st] Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130)

Bibliography :
[31430553] The association between genetic polymorphisms of interleukin 23 receptor gene and the risk of rheumatoid arthritis: An updated meta-analysis.
[31253169] Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis.
[31202965] Functional characterization of three fish-specific interleukin-23 isoforms as regulators of Th17 signature cytokine expression in grass carp head kidney leukocytes.
[31123953] Interleukin-23 receptor (IL-23R) gene polymorphisms and haplotypes associated with the risk of preeclampsia: evidence from cross-sectional and in silico studies.
[31079916] Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β.
[31029042] IL-23 and dendritic cells: What are the roles of their mutual attachment in immune response and immunotherapy?
[31020341] Critical role of interleukin-23 in development of asthma promoted by cigarette smoke.
[31002919] NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice.
[30942097] Associations between IL-23R gene polymorphisms and the susceptibility of rheumatoid arthritis: a meta-analysis.
[30543324] is a microRNA safeguard for -induced inflammatory colon oncogenesis.